WallStreetZenWallStreetZen

NASDAQ: ALEC
Alector Inc Stock Forecast, Predictions & Price Target

Analyst price target for ALEC

Based on 1 analyst offering 12 month price targets for Alector Inc.
Min Forecast
$35.00+531.77%
Avg Forecast
$35.00+531.77%
Max Forecast
$35.00+531.77%

Should I buy or sell ALEC stock?

Based on 1 analyst offering ratings for Alector Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALEC stock forecasts and price targets.

ALEC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-20

1 of 1

Forecast return on equity

Is ALEC forecast to generate an efficient return?
Company
44.18%
Industry
73.55%
Market
80.54%
ALEC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALEC forecast to generate an efficient return on assets?
Company
12.44%
Industry
31.45%
ALEC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALEC earnings per share forecast

What is ALEC's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
-$1.93
Avg 2 year Forecast
-$1.78
Avg 3 year Forecast
-$1.32

ALEC revenue forecast

What is ALEC's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$65.5M-32.06%
Avg 2 year Forecast
$95.4M-1.09%
Avg 3 year Forecast
$136.5M+41.63%
ALEC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALEC revenue growth forecast

How is ALEC forecast to perform vs Biotechnology companies and vs the US market?
Company
11.64%
Industry
37.19%
Market
10.57%
ALEC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALEC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALEC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALEC$5.54$35.00+531.77%Buy
CTNM$20.77$28.00+34.81%Strong Buy
MNMD$7.46$26.67+257.47%Buy
THRD$12.98$20.50+57.94%Strong Buy
LENZ$21.03$31.33+48.99%Strong Buy

Alector Stock Forecast FAQ

Is Alector Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ALEC) stock is to Buy ALEC stock.

Out of 1 analyst, 0 (0%) are recommending ALEC as a Strong Buy, 1 (100%) are recommending ALEC as a Buy, 0 (0%) are recommending ALEC as a Hold, 0 (0%) are recommending ALEC as a Sell, and 0 (0%) are recommending ALEC as a Strong Sell.

If you're new to stock investing, here's how to buy Alector stock.

What is ALEC's earnings growth forecast for 2024-2026?

(NASDAQ: ALEC) Alector's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.02%.

Alector's earnings in 2024 is -$120,613,000.On average, 7 Wall Street analysts forecast ALEC's earnings for 2024 to be -$185,607,751, with the lowest ALEC earnings forecast at -$197,588,352, and the highest ALEC earnings forecast at -$170,600,675. On average, 6 Wall Street analysts forecast ALEC's earnings for 2025 to be -$171,728,374, with the lowest ALEC earnings forecast at -$228,431,412, and the highest ALEC earnings forecast at -$95,420,716.

In 2026, ALEC is forecast to generate -$126,909,553 in earnings, with the lowest earnings forecast at -$132,046,850 and the highest earnings forecast at -$116,625,320.

What is ALEC's revenue growth forecast for 2024-2026?

(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 11.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.57%.

Alector's revenue in 2024 is $96,406,000.On average, 4 Wall Street analysts forecast ALEC's revenue for 2024 to be $6,313,188,811, with the lowest ALEC revenue forecast at $6,127,166,606, and the highest ALEC revenue forecast at $6,448,127,198. On average, 4 Wall Street analysts forecast ALEC's revenue for 2025 to be $9,190,460,756, with the lowest ALEC revenue forecast at $4,129,114,636, and the highest ALEC revenue forecast at $19,276,912,400.

In 2026, ALEC is forecast to generate $13,160,733,634 in revenue, with the lowest revenue forecast at $10,343,027,348 and the highest revenue forecast at $18,478,848,227.

What is ALEC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALEC) forecast ROA is 12.44%, which is lower than the forecast US Biotechnology industry average of 31.45%.

What is ALEC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ALEC price target, the average ALEC price target is $35.00, with the highest ALEC stock price forecast at $35.00 and the lowest ALEC stock price forecast at $35.00.

The Wall Street analyst predicted that Alector's share price could reach $35.00 by Jun 20, 2025. The average Alector stock price prediction forecasts a potential upside of 531.77% from the current ALEC share price of $5.54.

What is ALEC's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ALEC) Alector's current Earnings Per Share (EPS) is -$1.38. On average, analysts forecast that ALEC's EPS will be -$1.93 for 2024, with the lowest EPS forecast at -$2.05, and the highest EPS forecast at -$1.77. On average, analysts forecast that ALEC's EPS will be -$1.78 for 2025, with the lowest EPS forecast at -$2.37, and the highest EPS forecast at -$0.99. In 2026, ALEC's EPS is forecast to hit -$1.32 (min: -$1.37, max: -$1.21).

What is ALEC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALEC) forecast ROE is 44.18%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.